| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/31/1993 | EP0534539A1 Process for preparing enantiomerically pure imidazo[4,5,1-jk]-[1,4]-benzodiazepin-2(1H)-thiones |
| 03/31/1993 | EP0534511A1 HIV protease inhibitors useful for the treatment of aids |
| 03/31/1993 | EP0534492A2 Carboxyalkyl substituted inhibitors of enkephalinase and ACE |
| 03/31/1993 | EP0534445A1 Process for the preparation of a medicament for oral or topical administration in the treatment of leishmaniasis |
| 03/31/1993 | EP0534443A1 3,6-Disubstituted pyridazine derivatives |
| 03/31/1993 | EP0534423A1 14-Hydroxy-N-(2-methoxyethyl)-7,8-dihydromorphine and -norisomorphine, process for their preparation and their use as medicines |
| 03/31/1993 | EP0534396A2 2-Substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/31/1993 | EP0534363A2 Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 03/31/1993 | EP0534344A1 Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines, a process for their preparation and their use as modulators of neurotransmitter function |
| 03/31/1993 | EP0534343A1 Substituted pyridinylamino-1H-indoles, 1H-indazoles, 2H-indazoles, benzo(b) thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments |
| 03/31/1993 | EP0534316A1 Use of alkylated polyethylenimines to concentrate bile acids |
| 03/31/1993 | EP0534310A1 Combination containing growth factors and polyelectrolytes |
| 03/31/1993 | EP0534304A1 Cycloalkylated polyethylenimines and their use as hypolipemic agents |
| 03/31/1993 | EP0534246A2 Benzylamine derivatives and medicines with antiarrhythmic activity containing them |
| 03/31/1993 | EP0534137A2 Kedarcidin antitumor chromophore |
| 03/31/1993 | EP0534097A2 Use of NADH or NADPH against cancer or AIDS |
| 03/31/1993 | EP0534033A1 Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form and compositions |
| 03/31/1993 | EP0533930A1 Use of a macrolide compound such as fk 506 for manufacturing a medicament for treating idiopathic thrombocytopenic purpura and basedow's disease |
| 03/31/1993 | EP0533920A1 THIOPYRANO 2,3-b]INDOLE DERIVATIVE |
| 03/31/1993 | EP0533904A1 Novel difluorinated quinolones, their preparation method and pharmaceutical compositions containing same |
| 03/31/1993 | EP0533902A1 A method for inhibition of retroviral replication |
| 03/31/1993 | EP0533878A1 Isoxazolyl imidazole derivatives, process for producing them and their use in medicaments |
| 03/31/1993 | EP0533846A1 The ciliary neurotrophic factor receptor |
| 03/31/1993 | EP0533845A1 USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER |
| 03/31/1993 | EP0533838A1 Nucleic acid ligands |
| 03/31/1993 | EP0533837A1 Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases |
| 03/31/1993 | EP0533834A1 Intercellular adhesion mediators |
| 03/31/1993 | EP0533833A1 Phosphorous prodrugs. |
| 03/31/1993 | EP0533832A1 Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| 03/31/1993 | EP0533827A1 Novel oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same. |
| 03/31/1993 | EP0533825A1 Ether lipid-nucleoside covalent conjugates. |
| 03/31/1993 | EP0533819A1 Hyperosmotic solutions for isonatremic resuscitation |
| 03/31/1993 | EP0533818A1 Process for activating reproduction of seasonal breeding animals by administering l-dihydroxyphenylalanine (l-dopa) |
| 03/31/1993 | EP0533804A1 Sigma binding site agents |
| 03/31/1993 | EP0533796A1 STEROIDAL 3-ACETIC ACID DERIVATIVES AS 5$g(a)-REDUCTASE INHIBITORS |
| 03/31/1993 | EP0533790A1 New salt form. |
| 03/31/1993 | EP0533770A1 Novel treatment |
| 03/31/1993 | EP0533744A1 Heterocyclic anthracyclione and anthracycline analogs |
| 03/31/1993 | EP0533724A1 Calcium citrate malate composition. |
| 03/31/1993 | EP0533703A1 Steroids which inhibit angiogenesis |
| 03/31/1993 | EP0533692A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
| 03/31/1993 | EP0533666A1 Use of calcium soap for the treatment of inflammatory skin reactions in horses and ponies |
| 03/31/1993 | EP0436650B1 Hydrated lipidic lamellar phases or liposomes based on ecdysteroids |
| 03/31/1993 | EP0407461B1 Novel cyclopentano-vitamin d analogs |
| 03/31/1993 | EP0309526B1 Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes |
| 03/31/1993 | EP0295248B1 Liposome preparation and antibiotic |
| 03/31/1993 | EP0265514B1 Medicaments for inhibiting skin wrinkling |
| 03/31/1993 | CN1070409A Prodrug activated by targeted catalytic proteins |
| 03/31/1993 | CN1070408A Trifluoromethylbenzylphosphonates useful in treating osteoperosis |
| 03/31/1993 | CN1070406A Preparation of cephalosporin antibiotic using syn-isomer of thiazolyl intermediate |
| 03/31/1993 | CN1070405A Diastereoisomer of 3-cephem-4-carbonic acid-1-(isopropxycarbonyloxy) ethylester and process for preparing same |
| 03/31/1993 | CN1070404A Heterocyclic derivatives |
| 03/31/1993 | CN1070403A betaarboline derivatives and process for preparing same and use in pharmaceuticals |
| 03/31/1993 | CN1070401A Production of beta-form thiamine hydrochloride crystals |
| 03/31/1993 | CN1070399A Substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
| 03/31/1993 | CN1070398A Process for preparation of cephalosporin antibiotic |
| 03/31/1993 | CN1070397A Indolesulphonamide-substituted dihydropyridines, processes for their preparation and their use in medicaments |
| 03/31/1993 | CN1070338A Manufacturing and using method of plaster for giving up smoking |
| 03/31/1993 | CN1070337A Ointments and ointment preparation |
| 03/31/1993 | CN1070323A Sustained-release matrices for dental application |
| 03/31/1993 | CN1020194C Method for preparation of difluorated nucleoside derivant |
| 03/31/1993 | CA2096825A1 Methods of preventing tissue damage associated with decreased blood flow by administration of aica riboside compounds |
| 03/31/1993 | CA2079361A1 Use of 4-amino-1-(2-pyridyl)piperidines as anti-convulsant and antiepileptic agents |
| 03/31/1993 | CA2077966A1 Method of and a composition for treatment of latent virus infection |
| 03/30/1993 | US5198567 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them |
| 03/30/1993 | US5198560 Cytotoxic bicyclo[7.3.1]tridec-4-ene-2,6-diyne compounds and process for the preparation thereof |
| 03/30/1993 | US5198552 Indole derivative having antiviral, interferon-inducing and immunomodulatory effects |
| 03/30/1993 | US5198533 Decapeptides |
| 03/30/1993 | US5198468 Essential fatty acid composition |
| 03/30/1993 | US5198466 Oxysulfonyl urea acat inhibitors |
| 03/30/1993 | US5198465 Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen |
| 03/30/1993 | US5198463 Oxytocin antagonists |
| 03/30/1993 | US5198460 Pyropheophorbides and their use in photodynamic therapy |
| 03/30/1993 | US5198459 Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents |
| 03/30/1993 | US5198457 Treatment of hyperthyroidism with 1,3-dihydro-1[2-(2-thienyl)alkyl]-2H-imidazole-2-thiones |
| 03/30/1993 | US5198454 3-Benzyl-5-/2-Bromoethyl/-2-/Methylimino/-4-Thiazolidone |
| 03/30/1993 | US5198451 Heterocyclic carboxylic acids |
| 03/30/1993 | US5198450 Phenylalkanoylamine derivatives, process for preparing the same, and usage of the same |
| 03/30/1993 | US5198448 Cardiotonics |
| 03/30/1993 | US5198447 Medicaments |
| 03/30/1993 | US5198446 Organosilane derivatives, pharmaceutical compositions containing them and process for preparing same |
| 03/30/1993 | US5198441 Derivatives of 1,2-dihydro 2-oxo quinoxalines, their preparation and their use in therapy |
| 03/30/1993 | US5198438 Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| 03/30/1993 | US5198436 Intraoral dosing method of administering trifluorobenzodiazepines |
| 03/30/1993 | US5198434 Angiotensin ii antagonizing fused pyridinyloxy containing derivatives |
| 03/30/1993 | US5198433 Hypotensive |
| 03/30/1993 | US5198432 Cytoprotective agents |
| 03/30/1993 | US5198430 Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them |
| 03/30/1993 | US5198250 Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using |
| 03/30/1993 | US5198228 Sodium carboxymethyl starch as both binder and disintegrating agent |
| 03/30/1993 | US5198226 Sustained release |
| 03/30/1993 | US5198225 Skin disorders or wound healing agents |
| 03/30/1993 | US5198223 Estrogen/Progesterone, Skin Permeation Enhancer |
| 03/30/1993 | US5198221 An inhalation composition containing medocromil sodium for obstructive airway disease |
| 03/30/1993 | US5198220 Drug delivery, polylactide/glycolide |
| 03/30/1993 | US5198211 Method of treating myocardial damage |
| 03/30/1993 | CA1315477C 2-amino acetamide derivatives |
| 03/30/1993 | CA1315476C Vanadyl organo-mineral compound, method for obtaining such a compound, pharmaceutical composition containing this organo-mineral compound |
| 03/30/1993 | CA1315474C Pristinamycin ii b derivatives, their preparation, and pharmaceutical compositions containing them |
| 03/30/1993 | CA1315473C 4-piperidinecarboxamide derivatives |